Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

SciClone reacquires rights to Zadaxin in Italy

April 27, 1998

FDA advisory committee will meet to discuss Lyme disease and cholera vaccines

April 24, 1998

First marketing approval for Novartis transplant drug

April 22, 1998

New immunosuppressants from Procept

April 22, 1998

Snow Brand Milk Products isolates two new immunosuppressants

April 22, 1998

Encouraging phase I/II results reported for TP-10

April 22, 1998

Novel TK inhibitors with immunosuppressant activity reported by R.W. Johnson

April 16, 1998

New approach to TB vaccination described by Merck

April 16, 1998

Vaccine against pneumococcal disease shown safe and immunogenic in children

April 14, 1998

Chemistry of new immunosuppressive triterpenoid elucidated by Merck & Co.

April 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...